10:28 ETAgentis Longevity Announces Acquisition of BioDesign, Expanding Its Leadership in Personalized Longevity, Performance Medicine & Advanced Health Optimization
Agentis Longevity has announced the acquisition of BioDesign, a Florida-based longevity healthcare company. This acquisition enhances Agentis's capabilities in personalized longevity and performance medicine, expanding its diagnostic and clinical offerings. BioDesign's co-founders will join Agentis in leadership roles to advance their shared mission of providing science-backed, individualized healthcare. The integration aims to improve healthspan and performance for clients, solidifying Agentis's position in the growing longevity sector.
prnewswire·
